Marya represents public and private life sciences companies in an eclectic range of complex transactions – including collaborations, license agreements, options to license or purchase, territory-specific licenses, joint venture and other profit-sharing arrangements, co-promotion relationships, and manufacture and supply agreements. She counsels clients with respect to the structuring and negotiation of agreements designed to maximize the value of the company's products and technology assets. She has particular expertise handling strategic alliances between biotechnology and pharmaceutical companies in areas as diverse as collaborative research and the development and marketing of late-stage pharmaceutical products.